Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System Lymphoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Central Nervous System Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university, Zhengzhou, Henan, China
Contact: Study coordinator (Zhihua Yao, M.D. Ph.D) · zlyyyaozhihua1260@zzu.edu.cn · +8613592622292
Contact: Principal Investigator (Zhihua Yao, M.D. Ph.D)
Contact: Principal Investigator (Yanyan Liu, M.D. Ph.D)

Study leads

Zhihua Yao, M.D. Ph.D
Study Director
Henan Cancer Hospital
Yanyan Liu, M.D. Ph.D
Study Director
Henan Cancer Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

Primary Central Nervous System Lymphoma · Secondary Central Nervous System Lymphoma · Relapsed Cancer

Abroad (travel likely)RecruitingPHASE2

Miami, United States

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Lymphoma

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Tampa, United States

A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating Methotrexate Combined With Rituximab,Sintilimab and Pirtobrutinib vs. Investigator-Selected Standard of Care in Treatment-Naive PCNSL

PCNSL · Primary Central Nervous System Lymphoma

Abroad (travel likely)RecruitingPHASE2

Xiamen, China · Wuhan, China

Pomalidomide, Anti-PD-1 Antibody Combined With Selinexor (PPS) in Relapsed/Refractory Primary Central Nervous System Diffuse Large B-Cell Lymphoma

Primary Central Nervous System Lymphoma (PCNSL) · Diffuse Large B Cell Lymphoma (DLBCL)

Abroad (travel likely)RecruitingPHASE2

Beijing, China